Why public health agencies cannot depend on good laboratory practices as a criterion for selecting data: the case of bisphenol A
Background In their safety evaluations of bisphenol A (BPA), the US Food and Drug
Administration (FDA) and a counterpart in Europe, the European Food Safety Authority
(EFSA), have given special prominence to two industry-funded studies that adhered to
standards defined by Good Laboratory Practices (GLP). These same agencies have given
much less weight in risk assessments to a large number of independently replicated non-
GLP studies conducted with government funding by the leading experts in various fields of …
Administration (FDA) and a counterpart in Europe, the European Food Safety Authority
(EFSA), have given special prominence to two industry-funded studies that adhered to
standards defined by Good Laboratory Practices (GLP). These same agencies have given
much less weight in risk assessments to a large number of independently replicated non-
GLP studies conducted with government funding by the leading experts in various fields of …